Institutional members access full text with Ovid®

Share this article on:

Combination therapy of 177Lu and 90Y Dotatate for treatment of neuroendocrine cancer

Ashton, Ceri E.a; Jeans, Stephen P.b; Valle, Juan W.c

Nuclear Medicine Communications: June 2014 - Volume 35 - Issue 6 - p 585–587
doi: 10.1097/MNM.0000000000000094
Editorial

aDepartment of Medical Physics, Royal United Hospital Bath NHS Trust, Bath

Departments of bNuclear Medicine

cMedical Oncology, The Christie NHS Foundation Trust, Manchester, UK

Correspondence to Ceri E. Ashton, MPhys (Hons), MSc, Department of Medical Physics, Royal United Hospital Bath NHS Trust, Combe Park, Bath BA1 3NG, UK Tel: +44 1225 821280; fax: +44 1225 821508; e-mail: ceri_cherry@talk21.com

Received August 17, 2013

Accepted January 24, 2014

© 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins